Results 111 to 120 of about 8,958 (210)

Emerging role of Natural killer cells in oncolytic virotherapy

open access: yes, 2015
Rauf Bhat, Jean Rommelaere Division of Tumor Virology, German Cancer Research Center, Heidelberg, Germany Abstract: Natural killer (NK) cells constitute a subtype of lymphocytes that initiate innate immune responses against tumors and virus-infected ...
Bhat R, Rommelaere J
core  

Oncolytic Virotherapy for human malignant mesothelioma: recent advances

open access: yes, 2015
International audienceCancer virotherapy is an attractive alternative to conventional treatments because it offers a wide range of antitumor effects due to 1) the diversity of the oncolytic viruses that are now available and 2) their multifaceted ...
Tangy, Frédéric   +5 more
core   +1 more source

A Cellular Automata Model of Oncolytic Virotherapy in Pancreatic Cancer

open access: yes, 2020
Oncolytic virotherapy is known as a new treatment to employ less virulent viruses to specifically target and damage cancer cells. This work presents a cellular automata model of oncolytic virotherapy with an application to pancreatic cancer.
Chen, J. (author)   +6 more
core   +1 more source

Oncolytic potency and reduced virus tumor-specificity in oncolytic virotherapy. A mathematical modelling approach. [PDF]

open access: yes, 2017
In the present paper, we address by means of mathematical modeling the following main question: How can oncolytic virus infection of some normal cells in the vicinity of tumor cells enhance oncolytic virotherapy?
De Pillis, Lisette   +7 more
core   +1 more source

Enhanced susceptibility of cancer cells to oncolytic rhabdo-virotherapy by expression of Nodamura virus protein B2 as a suppressor of RNA interference

open access: yesJournal for ImmunoTherapy of Cancer, 2018
Antiviral responses are barriers that must be overcome for efficacy of oncolytic virotherapy. In mammalian cells, antiviral responses involve the interferon pathway, a protein-signaling cascade that alerts the immune system and limits virus propagation ...
Donald Bastin   +8 more
doaj   +1 more source

Current perspectives of virotherapy as a cancer treatment strategy

open access: yesИнфекция и иммунитет
Analysis of scientific literature presented in the main databases (PubMed, CyberLeninka, Google Scholar, Scopus) evidence that after cardiovascular diseases malignant tumors hold the second place among the most common causes of mortality in both ...
Lyubov D. Vlasova
doaj   +1 more source

A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model

open access: yesMolecular Therapy: Oncolytics, 2017
Oncolytic virotherapy is a treatment approach with increasing clinical relevance, as indicated by the marked survival benefit seen in animal models and its current exploration in human patients with cancer.
Julius W. Kim   +9 more
doaj   +1 more source

Arming vaccinia virus for pancreatic cancer oncolytic virotherapy

open access: yes, 2011
PhDVaccinia virus is a 250-300nm enveloped DNA virus from the poxvirus family and is used as a vector for oncolytic viral gene therapy. No unique cell surface receptor has been identified for Vaccinia virus and the reasons for its tropism for cancer ...
Hiley, Crispin
core  

IgE‐Sensitized Mast Cells: A Programmable Platform for Antigen‐Triggered Oncolytic Virotherapy

open access: yes
MedComm – Future Medicine, Volume 5, Issue 1, March 2026.
Lin Chen, Yu‐Xuan Jin, Jin‐Lyu Sun
wiley   +1 more source

Markedly enhanced intratumoral spread and antitumor effect of oncolytic adenovirus expressing decorin

open access: yes, 2008
With the aim of improving viral distribution and tumor penetration, we have engineered decorin expressing replication-incompetent (dl-LacZ-DCNG) and -competent (Ad-[DELTA]E1B-DCNG) adenoviruses.
Joo-Hang Kim   +7 more
core  

Home - About - Disclaimer - Privacy